glp-1 analogs GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes GLP-1 Receptor Agonists as Treatments

Lowering its levels impairs fatty acid breakdown, resulting in aging of both orthotopic xenograft and genetically induced glioblastoma mouse models (53)

Both forms of the peptide are indistinguishable in their ability to produce biological effects through GLP-1 receptors located in pancreatic cells [3], gastric glands [4] and in adipocytes [5], lung [6] and brain [7-10]

Mechanism of Action Berberine LPT delivers its bioactive nutrients via oral liposomal technology, which ensures superior absorption and cellular delivery

Peptide-enhanced angiogenesis potentially critical for severe fractures, surgical bone grafts, or complex injuries where vascular ingrowth limiting factor